Article info

Download PDFPDF

Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab)
Free
  1. Correspondence to:
    Dr H A Liebman, Division of Hematology, Kenneth Norris Jr Cancer Center, MS 34, 1441 Eastlake Ave, Los Angeles, CA 90033, USA;
    liebman{at}hsc.usc.edu
View Full Text

Citation

Arzoo K, Sadeghi S, Liebman HA
Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab)

Publication history

  • Accepted February 12, 2002
  • First published October 1, 2002.
Online issue publication 
October 01, 2002

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.